1. Biodegradable nanoplatforms for antigen delivery: part II - nanoparticles, hydrogels, and microneedles for cancer immunotherapy.
- Author
-
Burgos JM, Vega E, García ML, Pujol M, Sánchez-López E, and Souto EB
- Subjects
- Humans, Animals, Hematologic Neoplasms therapy, Hematologic Neoplasms immunology, Receptors, Chimeric Antigen immunology, Drug Delivery Systems, Neoplasms therapy, Neoplasms immunology, Hydrogels chemistry, Immunotherapy, Adoptive methods, Needles, Nanoparticles
- Abstract
Introduction: In recent years, chimeric antigen receptor T (CAR-T) cell therapy has resulted in a breakthrough in the treatment of patients with refractory or relapsed hematological malignancies. However, the identification of patients suitable for CAR-T cell therapy needs to be improved., Areascovered: CAR-T cell therapy has demonstrated excellent efficacy in hematological malignancies; however, views on determining when to apply CAR-T cells in terms of the evaluation of patient characteristics remain controversial., Expert Opinion: We reviewed the current feasibility and challenges of CAR-T cell therapy in the most common hematological malignancies and classified them according to disease type and treatment priority, to guide clinicians and researchers in applying and investigating CAR-T cells further.
- Published
- 2024
- Full Text
- View/download PDF